Clearmind Medicine (CMND) Schedule 13G/A: Nissim Daniel reports <5% stake

Rhea-AI Filing Summary

Clearmind Medicine Inc amendment reports that Nissim Daniel filed a Schedule 13G/A stating beneficial ownership in the issuer's common shares. The filing identifies the reporting person, citizenship (Israel), an address in Ramat Gan, and CUSIP 185053402, and states ownership of 5 percent or less of a class.

Insights

Corporate Governance Specialist

Routine ownership disclosure showing sub-5% holding.

The amendment records identity and basic holdings for Nissim Daniel, including address and citizenship. It classifies the position as "Ownership of 5 Percent or Less of a Class," which is a standard passive reporting category under beneficial ownership rules.

There is no disclosed change in voting or dispositive power; subsequent filings would show any material shifts.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

Clearmind Medicine Inc

(Name of Issuer)

Common Shares, no par value per share

(Title of Class of Securities)

12/31/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP Number(s):

1

Names of Reporting Persons

Nissim Daniel

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

ISRAEL

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

0.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0.00 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Clearmind Medicine Inc
(b)	Address of issuer's principal executive offices: 101 - 1220 West 6th Avenue, Vancouver, British Columbia V6H1A5
Item 2.
(a)	Name of person filing: Nissim Daniel
(b)	Address or principal business office or, if none, residence: 5 Harav Levin Street, Ramat Gan, Israel 5226039
(c)	Citizenship: Israel
(d)	Title of class of securities: Common Shares, no par value per share
(e)	CUSIP No.: 185053402
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: See items 5-11 of the cover pages hereto for beneficial ownership, percentage of class and dispositive power of the Reporting Person, which is incorporated herein
(b)	Percent of class: See items 5-11 of the cover pages hereto for beneficial ownership, percentage of class and dispositive power of the Reporting Person, which is incorporated herein.
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: See items 5-11 of the cover pages hereto for beneficial ownership, percentage of class and dispositive power of the Reporting Person, which is incorporated herein.
	(ii) Shared power to vote or to direct the vote: See items 5-11 of the cover pages hereto for beneficial ownership, percentage of class and dispositive power of the Reporting Person, which is incorporated herein.
	(iii) Sole power to dispose or to direct the disposition of: See items 5-11 of the cover pages hereto for beneficial ownership, percentage of class and dispositive power of the Reporting Person, which is incorporated herein.
	(iv) Shared power to dispose or to direct the disposition of: See items 5-11 of the cover pages hereto for beneficial ownership, percentage of class and dispositive power of the Reporting Person, which is incorporated herein.
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Nissim Daniel

Signature:	/s/ Nissim Daniel
Name/Title:	Nissim Daniel
Date:	03/09/2026

FAQ

What does the Schedule 13G/A from CMND say about Nissim Daniel's holdings?

The filing states Nissim Daniel holds 5 percent or less of Clearmind Medicine common shares. It provides the reporting person's citizenship (Israel), an address in Ramat Gan, and the CUSIP 185053402 as identification details.

Does the Schedule 13G/A disclose voting or dispositive power for CMND shares?

The amendment refers readers to the cover items for voting and dispositive power and otherwise repeats the standard cover-page language. No specific sole or shared voting or dispositive percentages beyond the sub-5% classification are stated in the excerpt.

Is the reported interest in CMND classified as greater than 5%?

No. The filing explicitly states the position is "Ownership of 5 Percent or Less of a Class." That classification indicates the reporting person does not exceed the five-percent beneficial ownership threshold under the Schedule 13G/A filing.

What identifying information does the CMND amendment provide about the filer?

The amendment lists the filer's name as Nissim Daniel, residence address in Ramat Gan, Israel, citizenship as Israel, and the class title as Common Shares with CUSIP 185053402